Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS

    Q301 - CLONOSEQ MEASURABLE RESIDUAL DISEASE (MRD) TESTING SERVICES

    DEPARTMENT OF VETERANS AFFAIRS
    Sol. 36C25026Q0104Special NoticeDAYTON, OH
    Closed
    STATUS
    Closed
    closed Nov 12, 2025
    POSTED
    Nov 4, 2025
    Publication date
    NAICS CODE
    621511
    Primary industry classification
    PSC CODE
    Q301
    Product & service classification

    AI Summary

    The Department of Veterans Affairs intends to negotiate a sole source contract for clonoSEQ measurable residual disease testing services with Adaptive Biotechnologies. This opportunity is under Simplified Acquisition Procedures, and responses must demonstrate capability by November 12, 2025. No solicitation package is available, and competition is not anticipated.

    Contract details

    Solicitation No.
    36C25026Q0104
    Notice Type
    Special Notice
    Posted Date
    November 4, 2025
    Response Deadline
    November 12, 2025
    NAICS Code
    621511AI guide
    PSC / Class Code
    Q301
    Primary Contact
    Thomas Bellamy
    City
    DAYTON
    State
    OH
    ZIP Code
    45428
    AI Product/Service
    service

    Description

    Notice of Intent to Sole-Source Requirement:
    The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 621511, Size Standard is $41.5 Million. The Product Service Code (PSC) is Q301.

    The sole-source contract will be awarded to:
    ADAPTIVE BIOTECHNOLOGIES CORPORATION
    UEI: DMW5BNQ331K9


    Description of requirements:
    The VA Northeast Ohio Healthcare System (VANEOHS), Pathology and Laboratory Medicine Service (PALMS), requires molecular minimal residual disease (MRD) testing services utilizing the clonoSEQ Assay provided exclusively by Adaptive Biotechnologies. The clonoSEQ Assay is a proprietary, patented molecular test developed and performed exclusively by Adaptive Biotechnologies. Adaptive Biotechnologies is the sole source provider of clonoSEQ MRD testing within the United States.


    It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.                                                                                                                                                           
    This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government.                                                                                                                                                                                         
    The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government.                                                                                                                                                   
    All responses to this intent to sole source must be emailed to Thomas Bellamy @ thomas.bellamy@va.gov by 3:00 p.m. EST November 12th, 2025.
     

    Key dates

    1. November 4, 2025Posted Date
    2. November 12, 2025Proposals / Responses Due

    AI search tags

    Frequently asked questions

    Q301 - CLONOSEQ MEASURABLE RESIDUAL DISEASE (MRD) TESTING SERVICES is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.